Endpoint Clinical provides interactive response technology (IRT) systems and solutions tailored for the life sciences industry, aiding sponsors and pharmaceutical companies in achieving clinical trial success. Since its inception in 2009, the company has aimed to streamline processes, enhance supply chain efficiency, and ensure accurate patient dosing through its proprietary PULSE platform. Headquartered in Wakefield, Massachusetts, with additional offices across the United States, Europe, and Asia, Endpoint Clinical takes a collaborative approach, working closely with clients to deliver customized solutions that minimize operational costs and improve clinical outcomes. As a subsidiary of Fortrea Holdings, Inc., Endpoint prioritizes quality, innovation, and client satisfaction in its mission to transform the landscape of clinical trials.